Principal Financial Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,396
| Closed | -$243K | – | 2476 |
|
|
2024
Q1 | $243K | Buy |
15,396
+515
| +3% | +$8.12K | ﹤0.01% | 2138 |
|
|
2023
Q4 | $225K | Buy |
14,881
+241
| +2% | +$3.65K | ﹤0.01% | 2134 |
|
|
2023
Q3 | $294K | Buy |
14,640
+559
| +4% | +$11.2K | ﹤0.01% | 2066 |
|
|
2023
Q2 | $397K | Buy |
14,081
+603
| +4% | +$17K | ﹤0.01% | 2006 |
|
|
2023
Q1 | $232K | Sell |
13,478
-922
| -6% | -$15.9K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $290K | Buy |
14,400
+2,509
| +21% | +$50.5K | ﹤0.01% | 2106 |
|
|
2022
Q3 | $257K | Buy |
11,891
+1,011
| +9% | +$21.9K | ﹤0.01% | 2133 |
|
|
2022
Q2 | $306K | Sell |
10,880
-982
| -8% | -$27.6K | ﹤0.01% | 2172 |
|
|
2022
Q1 | $547K | Buy |
11,862
+303
| +3% | +$14K | ﹤0.01% | 2097 |
|
|
2021
Q4 | $972K | Sell |
11,559
-4,272
| -27% | -$359K | ﹤0.01% | 1987 |
|
|
2021
Q3 | $1.06M | Buy |
15,831
+1,140
| +8% | +$76K | ﹤0.01% | 1996 |
|
|
2021
Q2 | $782K | Buy |
14,691
+8,780
| +149% | +$467K | ﹤0.01% | 2104 |
|
|
2021
Q1 | $256K | Sell |
5,911
-1,021
| -15% | -$44.2K | ﹤0.01% | 2320 |
|
|
2020
Q4 | $360K | Buy |
+6,932
| New | +$360K | ﹤0.01% | 2199 |
|